These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 6373080)

  • 41. Transfusion therapy in congenital hemolytic anemias.
    Sharon BI
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1053-86. PubMed ID: 7860437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-transfusional iron overload in the haemoglobinopathies.
    Thuret I
    C R Biol; 2013 Mar; 336(3):164-72. PubMed ID: 23643400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isovolumetric partial exchange transfusion in the management of sickle cell disease in pregnancy.
    Nagey DA; Garcia J; Welt SI
    Am J Obstet Gynecol; 1981 Oct; 141(4):403-7. PubMed ID: 7282822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current approach to iron chelation in children.
    Aydinok Y; Kattamis A; Viprakasit V
    Br J Haematol; 2014 Jun; 165(6):745-55. PubMed ID: 24646011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
    Liem RI; O'Gorman MR; Brown DL
    Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Red cell transfusion in paediatric patients with thalassaemia and sickle cell disease: Current status, challenges and perspectives.
    Tzounakas VL; Valsami SI; Kriebardis AG; Papassideri IS; Seghatchian J; Antonelou MH
    Transfus Apher Sci; 2018 Jun; 57(3):347-357. PubMed ID: 29880248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness, safety, and cost of partial exchange transfusions in patients with sickle-cell anemia at a sickle cell disease center in sub-Saharan Africa.
    Boma Muteb P; Kaluila Mamba JFJ; Muhau Pfutila P; Bilo V; Panda Mulefu JD; Diallo DA
    Med Sante Trop; 2017 Nov; 27(4):387-391. PubMed ID: 29313505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Transfusion in sickle cell anemia].
    Germain S; Brahimi L; Rohrlich P; Benkerrou M; Gerota I; Ballerini P
    Pathol Biol (Paris); 1999 Jan; 47(1):65-72. PubMed ID: 10081782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liver histopathologic findings in women with sickle cell disease given prophylactic transfusion during pregnancy.
    Yeomans E; Lowe TW; Eigenbrodt EH; Cunningham FG
    Am J Obstet Gynecol; 1990 Sep; 163(3):958-64. PubMed ID: 2403175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Iron overload in sickle cell anemia : a study of 94 patients].
    Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
    Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crises in Sickle Cell Disease.
    Novelli EM; Gladwin MT
    Chest; 2016 Apr; 149(4):1082-93. PubMed ID: 26836899
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transfusing children with hemoglobinopathies.
    Allali S; Taylor M; Albinni S; Amiranoff D; de Montalembert M
    Transfus Clin Biol; 2019 Sep; 26(3):147-149. PubMed ID: 31300265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical management of sickle cell hemoglobinopathies during pregnancy.
    McLaughlin BN; Martin RW; Morrison JC
    Clin Perinatol; 1985 Oct; 12(3):585-97. PubMed ID: 3902313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neocytopheresis: a new approach for the transfusion of patients with thalassaemia major.
    Triadou P; Girot R; Rebibo D; Lemau D; Mattlinger B; Bolo P; Maier-Redelsperger M; Barritault L
    Eur J Pediatr; 1986 Apr; 145(1-2):10-3. PubMed ID: 3732311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sickle cell E hemoglobinopathy and pregnancy.
    Ramahi AJ; Lewkow LM; Dombrowski MP; Bottoms SF
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):493-5. PubMed ID: 3347442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Progress in the therapy of children with congenital hemolytic anemias by transfusion of neocyte concentrations. Initial experiences in the separation and transfusion of young erythrocytes, obtained with the cell separator Fenwal CS-3000].
    Heim MU; Eckstein R; Mittermüller H; Haas RJ; Schmidt P; Graebner E; Pape W; Mempel W
    Klin Padiatr; 1985; 197(2):98-100. PubMed ID: 3990160
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].
    Hladun R; Elorza I; Olivé T; Dapena JL; Llort A; Sánchez de Toledo J; Díaz de Heredia C
    An Pediatr (Barc); 2013 Aug; 79(2):75-82. PubMed ID: 23402775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice.
    Sii-Felice K; Giorgi M; Leboulch P; Payen E
    Exp Hematol; 2018 Aug; 64():12-32. PubMed ID: 29807062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.
    Kim HC; Dugan NP; Silber JH; Martin MB; Schwartz E; Ohene-Frempong K; Cohen AR
    Blood; 1994 Feb; 83(4):1136-42. PubMed ID: 8111053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.